Loss of vertebral bone and mechanical strength in estrogen-deficient rats is prevented by long-term administration of zoledronic acid.
about
Bisphosphonate therapy in pediatric patientsCharacterization of bone microstructure using photoacoustic spectrum analysis.Antiosteoporotic effects of Polycan in combination with calcium lactate-gluconate in ovariectomized rats.The impact of bisphosphonates on the osteoblast proliferation and Collagen gene expression in vitro.Mineral changes in osteoporosis: a review.Detecting early biomechanical effects of zoledronic Acid on femurs of osteoporotic female rats.Effects of microarchitecture on bone strength.Selection of the Optimal Herbal Compositions of Red Clover and Pomegranate According to Their Protective Effect against Climacteric Symptoms in Ovariectomized Mice.Anti-climacterium effects of pomegranate concentrated solutions in ovariectomized ddY mice.Update on the use of zoledronic acid in the management of osteoporosis.Influence of bisphosphonates on the osteoblast RANKL and OPG gene expression in vitro.Detecting early bone changes using in vivo micro-CT in ovariectomized, zoledronic acid-treated, and sham-operated rats.Zoledronate reverses mandibular bone loss in osteoprotegerin-deficient mice.Sequential treatment with monofluorophosphate and zoledronic acid in osteoporotic rats.Zoledronic acid prevents disuse osteopenia and augments gene expression of osteoclastic differentiation markers in mice.Effects of estrogen deficiency and bisphosphonate therapy on osteocyte viability and microdamage accumulation in an ovine model of osteoporosis
P2860
Q26830702-5B475500-A16D-448F-B162-8CA8C2C8BA3BQ30374368-DCC9A413-A0DA-4788-B9D9-8A376D19A848Q33962186-2B0EFF98-5013-4726-A387-565E40FA11A7Q34028940-51C6C7DF-07DD-4745-9EAA-AEF7D031E714Q34600560-5CE26D59-7B54-49F8-8C0E-66E4A7284DC6Q36486501-97A4ADD5-2D8C-47E7-B240-7DDD1EA2A7CFQ36830305-9B82DF00-6863-46BA-8FA0-FAD28D7CEAE8Q37202596-7EF45D9E-AF5F-4272-B5F7-595DC332736DQ37734780-E94717EB-3E81-4F3B-BA46-D5A80B286E2BQ37765866-073A2C35-E980-48BB-9B5C-EAB6B7817F1FQ39645440-C8BAD3A2-55E5-4B94-8FD2-038BB63CF8B1Q43265907-6FA77BD3-3AED-40A4-8694-58C3F4AA5A54Q46581893-E9FA464C-CD44-4FEC-90CB-BDAD2BBE2F30Q51186823-5BBA75C3-D64C-4E48-8675-015DCD586AF6Q55413820-E30D0BD4-B8ED-4E1F-87BF-E4F33912A302Q57879667-93FA6EFB-32B2-4B0C-A708-6607059E7921
P2860
Loss of vertebral bone and mechanical strength in estrogen-deficient rats is prevented by long-term administration of zoledronic acid.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Loss of vertebral bone and mec ...... nistration of zoledronic acid.
@en
Loss of vertebral bone and mec ...... nistration of zoledronic acid.
@nl
type
label
Loss of vertebral bone and mec ...... nistration of zoledronic acid.
@en
Loss of vertebral bone and mec ...... nistration of zoledronic acid.
@nl
prefLabel
Loss of vertebral bone and mec ...... nistration of zoledronic acid.
@en
Loss of vertebral bone and mec ...... nistration of zoledronic acid.
@nl
P2093
P1476
Loss of vertebral bone and mec ...... nistration of zoledronic acid.
@en
P2093
Alexander Pataki
G Paul Evans
Jonathan R Green
Markus Glatt
Simon B Hornby
P2888
P304
P356
10.1007/S00198-004-1588-3
P407
P577
2004-03-13T00:00:00Z